Skip to content

A randomized controlled trial of mindfulness-based cognitive therapy for body dysmorphic disorder: Impact on core symptoms, emotion dysregulation, and executive functioning.

Ying-Qi Gu, Yi Zhu

Journal of Behavior Therapy and Experimental Psychiatry December 2023 DOI: 10.1016/j.jbtep.2023.101869 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 116
Population Patients with body dysmorphic disorder (BDD)
Intervention Mindfulness-based cognitive therapy (MBCT)
Duration 8-week intervention with assessments at pre-treatment, post-treatment, and 3-month follow-up
Topics Meditation
Keywords Bdd Emotion dysregulation Executive functioning Mindfulness-based cognitive therapy
Key findings Patients with BDD who received 8 weeks of MBCT showed greater improvement than treatment-as-usual controls on self-reported and clinician-rated BDD symptoms, self-reported emotion dysregulation, and self-reported executive function, while improvement on executive function tasks was only partially supported. The authors report feasibility and acceptability were positive and conclude MBCT may be a useful intervention for BDD.

Abstract

Mindfulness-based cognitive therapy (MBCT) is garnering increasing empirical interest as an intervention for Body Dysmorphic Disorder (BDD), although no studies of mindfulness as a standalone treatment have included a sample composed entirely of patients with BDD or a comparison group. The aim of this study was to investigate the improvement of MBCT intervention on the core symptoms, emotional dysfunction, and executive function of BDD patients, as well as the feasibility and acceptability of MBCT training. Patients with BDD were randomized into an 8-week MBCT group (n = 58) or treatment-as-usual (TAU) control group (n = 58) and were assessed at pre-treatment, post-treatment, and 3-month follow-up. Participants who received MBCT showed greater improvement on self-reported and clinician ratings of BDD symptoms, self-reported emotion dysregulation symptoms and executive function compared with TAU participants. Improvement for executive function tasks was partially supported. In addition, feasibility and acceptability of MBCT training were positive. There is no systematic assessment of the severity of key potential outcome variables associated with BDD. MBCT may be a useful intervention for patients with BDD, improving patients' BDD symptoms, emotion dysregulation, and executive functioning.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics